Acidity and hypoxia are crucial phenotypes of tumour microenvironment both contributing to the selection of malignant cells under a micro evolutionistic pressure. During the tumour progression, nanovesicles, called exosomes and the metalloenzyme carbonic anhydrase IX (CA IX) affect the tumour growth and proliferation. Exosomes are released into the tumour microenvironment and spilt all over the body, while CA IX is a tumour-associated protein overexpressed in many different solid tumours. In the present study, to better understand the relationships between exosomes and CA IX, it has been used an in vitro cellular model of cells cultured in different pH conditions. The results showed that the acidic microenvironment induced upregulation of both expression and activity of CA IX in cancer cells and their exosomes, together with increasing the number of released exosomes. These data strongly support the importance of CA IX as a cancer biomarker and as a valuable target of new anticancer therapies.
Introduction
In the last decade, the importance of exosomes has gained attention for their role in intercellular communication. They are cell-derived nanovesicles (40-180 nm) shuttling proteins, DNA, and RNA that could be transferred to recipient cells and modulate their protein expression 1, 2 . Exosomes membrane is composed of a lipid bilayer enriched in cholesterol and sphingomyelin (typically lipid rafts components 3 ), in ceramide (essential for the insertion of microRNAs into exosomes 4 ) and Bis (monoacylglycero) phosphate (BMP) (an exosome-specific marker 5 ). Exosomes are released from cells in physiological and pathological conditions, including cancer. It has been demonstrated that cancer cells produce more exosomes as compared to normal cells, and cancer exosomes differ from normal exosomes in molecular composition and function 6 . The tumour microenvironment is acidic, a common feature of virtually all cancers 7 . The extracellular acidity has a strong influence on the tumour microenvironment fitness, with a critical role in the progressive microevolution of cancers, including the induction of increased exosome release [7] [8] [9] [10] . Tumour pH ranges in vivo from 6 to 6.8, with a mean of 6.5 and it is correlated to tumour malignancy [11] [12] [13] [14] [15] [16] [17] . In addition to low pH, tumour microenvironment is characterised by hypoxia and low nutrients supply, and a typical sign of malignancy that is the so-called aerobic glycolysis, also called Warburg Effect, i.e. sugar fermentation in hypoxic condition 7, [18] [19] [20] [21] . These cells produce ATP converting glucose in lactic acid, rather than metabolising it in mitochondria through oxidative phosphorylation 20, [22] [23] [24] [25] . However, this process implies an increase of glucose absorption to sustain energy requirement by tumour cells. The most important product of tumour metabolism is lactate leading in turn to H + accumulation in the extracellular microenvironment with a direct consequence of the low pH 26 . High levels of carbonic dioxide produced during mitochondrial respiration of oxygenated cancer cells also contribute to a substantial release of H + into the tumour microenvironment [27] [28] [29] [30] [31] [32] . Low extracellular pH, lactic and carbonic acid production, uncontrolled growth, low blood and nutrient supply, contribute to generate a tumour microenvironment extremely toxic to normal cells. The toxic microenvironment progressively selects malignant cells, able to survive in this adverse condition thanks to up-regulation of expression and activity of several proton extrusion mechanisms, which release protons and lactate into extracellular microenvironment avoiding cytosol acidification 33, 34 . In fact, an anti-acidic approach based on either Proton Pump Inhibitors (PPI) 9, 35 or buffers leads to acidification of cancer cell cytosol followed by quick and non-conventional cell death. Moreover, the anti-acidic treatment sensitises cancer cells to chemotherapeutics 12, 15, 16 , supporting the use of PPI as a new strategy against cancer [36] [37] [38] . Among proton flux regulator 21 there are vacuolar H + -ATPases (V-ATPases), Na + /H + exchanger (NHE), monocarboxylate transporters (MCTs), carbonic anhydrase IX (CA-IX) 10, 33, 34 , and Na + /HCO 3 co-transporters (NBC) 39 . Interference (i.e. inhibition) with one or more of these proton pumps leads to a potent inhibition of cancer growth in a variety of ex vivo and in vivo models [40] [41] [42] . In this context, a pivotal role has been attributed to the CA IX, which is a metalloenzyme well studied in cancer. CA IX belongs to the α-CA genetic family among the seven CA-families known up to date. 46 . This study hypothesised that some of the proton exchangers, extremely active in malignant cancer cells, could be expressed on exosomes and actively modulated by the acidic conditions. To this purpose, we explored the expression and activity of CA IX in cancer cells and cancer-released exosomes showing that CA IX expression and related activity are up-regulated under the acidic condition in both cells and exosomes. These results support a key role of CA IX in cancer progression and as both a cancer biomarker and a therapeutic target.
Materials and methods

Cell line
Human prostate carcinoma cell line (LNCaP) is derived from a metastatic site (left supraclavicular lymph node) of a 50-year-old Caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma (Istituto dei tumori di Milano). Tumour cells were negative for Mycoplasma contamination as routinely tested by PCR (Venor ® GeM, Minerva Biolabs, Germany). The cells were maintained in RPMI culture medium supplemented with antibiotics and 10% foetal calf serum (FCS) (Invitrogen, Milan, Italy). Experiments were performed in buffered medium at pH 7.4 and in RPMI 1640 medium without sodium bicarbonate (pH 6.5) supplemented with antibiotics and 10% foetal calf serum (FCS) (Invitrogen, Milan, Italy). The acid cell culture medium (pH 6. 
Confocal microscopy analysis
Cells were fixed 10 min in 4% paraformaldehyde, blocked 30 min in PBS with 1% BSA and labelled overnight with M75 antibody in blocking solution 47 . After washing with PBS +0.02% Tween20, cells were labelled with anti-mouse conjugated with AlexaFluor-488 and then with DAPI + ProLong (P36931, ThermoFisher Scientific).
Images were taken by a FV1000 confocal microscope (Olympus, Tokyo, Japan), using a (Olympus) planapo objective 60x oil A.N. 1.42. Excitation light was obtained by a Laser Dapi 408 nm for DAPI, an Argon Ion Laser (488 nm) for Alexa 488, DAPI emission was recorded from 415 to 485 nm, AlexaFluor-488 emission was recorded from 525 to 550 nm.
Exosomes isolation from supernatant cell culture media
After 5 days of cell cultures, supernatants were collected, and exosomes isolated as described in Théry et al. and Kusuzaki et al 48 . Briefly, after centrifugation of cell at 300 g for 5 min, supernatants were centrifuged at 1200 g for 15 min followed by 12,000 g for 30 min. Supernatants were then filtered using a 0.22 μm filter (Millipore Corp., Bedford, MA) and centrifuged at 110,000 g for 1 h in a Sorvall WX Ultracentrifuge Series (Thermo Fisher Scientific) in order to pellet exosomes. After one wash in a large volume of phosphate-buffered saline (PBS), exosomes were resuspended in PBS (50 μl) for subsequent experimental analysis. To eliminate exosomes of FCS, the FCS was filtered with 0.45 and subsequently 0.22 μm filters (Millipore Corp., Bedford, MA) and then ultracentrifuged at 110,000 g before its addition to the culture media.
Western blot analysis
Lysates were prepared in CHAPS buffer (10 mM Tris-HCl [pH 7.4], MgCl2 1 mM, EGTA 1 mM, CHAPS 0.5%, glycerol 10%, β-mercaptoethanol 5 mM, PMSF 1 mM) containing protease inhibitor cocktail. Cell lysates and exosomes were subjected to electrophoresis on SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Protran Whatman, Dassel, Germany). After blocking in 5% dry milk in PBS1X, membranes were hybridised with primary antibodies: M75 47 , anti-Tsg101 (4A10, GeneTex, USA), anti-GAPDH (GA1R, Santa Cruz Biotechnology, USA) and anti-actin (C4, Santa Cruz Biotechnology, USA) monoclonal antibodies. After incubation with appropriate peroxidase-conjugated anti-IgG (Amersham Biosciences, Milan, Italy), membranes were revealed using the ECL Chemiluminescent Substrate, (ThermoFisher Scientific).
Enzyme activity
LNCaP cells and their exosomes were obtained from cellular cultures grown at pH 7.4 and 6.5 as described above. Cell and exosome extracts were prepared at 4°C using the lysis buffer containing 1% Triton X-100, 10 mM Tris-HCl (pH 7.4), MgCl2 1 mM, EGTA 1 mM, CHAPS 0.5%, glycerol 10%, β-mercaptoethanol 5 mM, and supplemented with a cocktail of protease inhibitors. Lysates were collected and clarified by centrifugation at 16,300×g for 15 min at 4°C. Aliquots of cell or exosomes extracts containing 1 µg of total protein were used to determining the hydratase activity. The enzymatic assay was performed at 0°C using CO 2 as substrate following the pH variation due to the catalysed conversion of CO 2 to bicarbonate. Bromothymol blue was used as the indicator of pH variation. The production of hydrogen ions during the CO 2 hydration reaction lowers the pH of the solution until the colour transition point of the dye is reached. The time required for the colour change is inversely related to the quantity and activity of CAs present in the sample. Wilbur-Anderson units were calculated according to the following definition: One Wilbur-Anderson unit (WAU) of activity is defined as (T0 − T)/T, where T0 (uncatalysed reaction) and T (catalysed reaction) are recorded as the time (in seconds) required for the pH to drop from 8.3 to the transition point of the dye (pH 6.8) in a control buffer and in the presence of enzyme, respectively. Enzyme activity was expressed as WAU/µg of total protein. Protein concentration was determined using the Bio-Rad protein assay.
Results
CA IX expression is up-regulated in human prostate carcinoma cell line (LNCaP) cultured in acidic condition
A human prostate cancer cell line (LNCaP) was cultured at two different pH conditions. LNCaP cells were buffered at pH 7.4 and 6.5, with no differences in terms of survival and viability as previously shown 6 . We checked the cell mortality (Trypan blue assay)(11) by cytofluorimeter analysis with again no differences in terms of mortality (1-2%) in both the cell pH culture conditions (data not shown). To evaluate the CA IX expression in LNCaP cells cultured at different pH, we first performed a Confocal Microscopy analysis. CA IX, predominantly expressed at the plasma membrane, can also be found into the cytoplasm and associated with the nuclear membrane. As shown in Figure 1 , CA IX while expressed in both samples, independently from the culture condition, it was upregulated in LNCaP cultured at pH 6.5 (Figure 1(b) ). Remarkably, in LNCaP pH 6.5 (Figure 1(b) ) CA IX showed an intracellular expression with a granular distribution as compared to the pH 7.4 culture condition (Figure 1(a) ).
CA IX expression is up-regulated in human prostate carcinoma cell line (LNCaP) cultured in acidic condition and in exosomes isolated from cell culture supernatant To validate the different CA IX expression, we performed a Western Blot Analysis; as shown in Figure 2 , CA IX is characterised by the presence of two bands (58/54 kDa) with an up-regulated expression in cells cultured under acidic condition compared to pH 7.4 (1.5-fold higher calculated with densitometry software ImageJ) (data not shown). This result was consistent with previous reports showing that CA IX higher expression was associated with acidic microenvironment [49] [50] [51] . Horie et al. 52 , demonstrated the presence of CA IX associated with exosomes fractions after OptiPrep density gradient centrifugation, so we analysed the whole exosomal purification lysates by Western Blot Analysis. Exosomes were characterised and quantified by Nanoparticle Tracking Analysis (NTA) (data not shown) and the expression of Tsg101, a typical exosomal marker. Consistent with the results obtained in cellular lysates, we showed that the CA IX expression in exosomes was up-regulated in acidic condition as compared to the 7.4 buffered condition (2.3-fold higher calculated with densitometry software) (data not shown). We also displayed that there was a different expression of the two CA IX bands (58/ 54 kDa) between cells and exosomes. In fact, cells extracts showed higher expression of 58 kDa CA IX while exosome preparation showed higher expression of the 54 kDa band. Interestingly, 54 kDa-form is always up-regulated in pH 6.5 condition both in cells and exosomes, suggesting to be the results of posttranscriptional changes of CA IX expression induced by the acidic state.
CA enzymatic activity analysis of LNCaP cells and exosomes
As shown in Figure 3 , the CA-activity has been found only in LNCaP cells and in the exosomes isolated from LNCaP cells grown at pH 6.5, while it was undetectable in LNCaP cells and in exosomes isolated from LNCaP cells grown at pH 7.4. These results are supported by the fact that the hypoxia condition, a state of all solid tumours, stimulates the hypoxia-inducible factor 1 (HIF-1), which induces the expression of the CA IX. The enzyme activity is responsible for the intracellular acidification and the acidity of the extracellular tumour microenvironment.
Acidic microenvironment influences cellular and exosomal CA IX expression.
Considering that CA IX expression is related to microenvironmental pH, we cultured LNCaP cell line at different pH conditions 6 ranging from 7.4 to 6.5 and vice-versa. After five days, cells were lysed to perform Western Blot Analysis and cell culture media were collected to obtain exosome purifications and perform WB analysis. CA IX expression in LNCaP cells progressively increased with the decrease of pH (Figure 4(a) ), while decreasing with the increase of microenvironmental pH (Figure 4(b) ). The same for the exosomes release at the different pH conditions from pH 7.4 to 6.5 (Figure 4(c) ) and vice-versa (Figure 4(d) ). NTA showed that pHrelated change in CA IX expression was directly related to the number and size of exosomes released by the cells (i.e. higher number in acidic conditions lower at pH 7.4) (Supplementary Figure 1 and Figure 2 , Supplementary Table 1 and Table 2 ).
Discussion and conclusions
Tumour microenvironment (TME) exerts a key role in cancer pathogenesis, including initiation, progression, and response to therapy. As described in the literature, low pH, hypoxia and low blood and nutrients supply all contribute to setting a very hostile and selective microenvironment, that is common to virtually all cancers 11 . The adverse microenvironmental induces a Darwinian selection allowing the survival and proliferation of the cells most suited to live in those conditions. For example, malignant cells upregulate the expression of many proton-efflux regulators to avoid the acidification of the cytosol, which leads to a quick cell death 33, 53 . Among these proton-efflux regulators, there are several CAs, zinc metalloenzymes catalysing the conversion of carbon dioxide to bicarbonate and protons. CAs are expressed in almost all living organisms and they are involved in many physiological processes based on transport and pH balance (respiration, digestion, renal acidification, bone resorption etc 45, 54 . Several isoforms are known and CA IX is markedly associated with solid tumours and by the way to the acidification of the tumour microenvironment pH [49] [50] [51] ; thus representing a suitable target in cancer therapy 45 ,51,55-58 . Recently, exosomes acquired a crucial role in the oncologic scenario since they are involved in cell-cell communication 59 , angiogenesis 52 , metastasis 60 and drug resistance 61 . Moreover, exosomes contain a cell-type specific signature, thus representing a source of biomarkers in a variety of diseases, including cancer 2, 6, 62, 63 . Furthermore, exosomes number and distribution could be included between the phenotypes common to virtually all cancers. We found, in fact, a higher number of exosomes in the plasma of cancer patients as compared to healthy donors 6, 62 , correlating with the results obtained in vitro models 6 . Since CA IX is a suitable marker of prostate cancer 64 and its expression is up-regulated in hypoxia condition 64, 65 , in the present paper we analysed how the acidic microenvironment of tumours could affect the CA IX expression and activity in human prostatic cancer cell line and exosomes released from them. The results showed different expression of CA IX in cells cultured in the acidic media (pH 6.5) respect to those at pH 7.4. The obtained results were consistent with the previous data showing that the low-pH is the most suitable condition for CA IX catalysis [49] [50] [51] . Moreover, the Confocal Analysis showed a remarkable expression of the protein in the cytoplasm of the cells cultured in the acidic microenvironment, with different internal distribution, suggesting that acidity influences CA IX expression and localisation within tumour cells. Notably, the CA IX expression in exosomes lysates reflected the CA IX expression at the cellular level in both acidic and physiological conditions. In addition, WB Analysis evidenced that the expression of the CA IX 54 kDa band increased in acidic condition at both cellular and exosome levels. All these experiments support the CA IX role in the in vivo tumour condition, since CA IX expression increased with progressive acidification and decreased with alkalinisation at both cellular and exosome levels. Thus, the tumour acidic microenvironment is the key factor in influencing the CA IX expression and activity in cancer cells and cancer-released exosomes. Previous reports have shown that CA IX is related to cancer development and progression 66 and some malignant cancer activities such as cell spreading and migration 67 . Therefore, the possibility to obtain exosomes from plasma samples of tumour patients may offer the opportunity to consider CA IX a key tumour biomarker. Considering that CA IX is involved in the metastatic activity of cancer cells 52, 68 , measuring its expression and activity in the exosomes may be helpful in monitoring cancer patients, as we have shown here for prostate cancer. Lastly, having exosomes a pivotal role in the metastatic process, both in preparing a metastatic niche and in inducing a tumour-like transformation in mesenchymal stem cells in target organs 60 , it is highly conceivable that the expression and activity of CA IX in tumour exosomes may be the key factor in the spreading of cancer all over the body. In conclusion, the future of anti-tumour strategies in primary cancers should be focussed in inhibiting the exosomes release and CA IX expression in malignant cancers. All strategies aimed at inhibiting microenvironmental acidity of tumours might represent a possible way to do it.
